http://pharmaweblog.com/blog/2006/06/28/lilly-keeps-fighting-says-biotech-patent-is-too-broad/ Pharmaceutical and biotech science and business Wed, 20 Aug 2008 11:03:31 +0000 http://wordpress.org/?v=2.0.2 http://pharmaweblog.com/blog/2006/06/28/lilly-keeps-fighting-says-biotech-patent-is-too-broad/#comment-21 Wed, 06 Sep 2006 13:41:25 +0000 http://pharmaweblog.com/blog/2006/06/28/lilly-keeps-fighting-says-biotech-patent-is-too-broad/#comment-21 [...] Ariad’s Patent Eviscerated. In the Pipeline:  As you’ll read in Derek Lowe’s post, The USPTO has completed its patent re-examination of Ariad’s patent that is under dispute in the lawsuit of Ariad v Lilly.  See my post from late June discussing Lilly’s appeal of the jury verdict in this case.  Share with the world: These icons link to social bookmarking sites where readers can share and discover new web pages. [...] […] Ariad’s Patent Eviscerated. In the Pipeline:  As you’ll read in Derek Lowe’s post, The USPTO has completed its patent re-examination of Ariad’s patent that is under dispute in the lawsuit of Ariad v Lilly.  See my post from late June discussing Lilly’s appeal of the jury verdict in this case.  Share with the world: These icons link to social bookmarking sites where readers can share and discover new web pages. […]

]]>